Results 11 to 20 of about 7,338 (215)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. [PDF]

PLoS ONE, 2020
BackgroundIt is now well recognised that the risk of severe COVID-19 increases with some long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs and there is a lack of data on the influence of multimorbidity (≥2 LTCs) on
Ross McQueenie, Hamish M E Foster, Bhautesh D Jani, Srinivasa Vittal Katikireddi, Naveed Sattar, Jill P Pell, Frederick K Ho, Claire L Niedzwiedz, Claire E Hastie, Jana Anderson, Patrick B Mark, Michael Sullivan, Catherine A O'Donnell, Frances S Mair, Barbara I Nicholl   +14 more
doaj   +2 more sources

Association of cardiometabolic multimorbidity with motoric cognitive risk syndrome in older adults

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
INTRODUCTION Motoric cognitive risk syndrome (MCR) is a predementia syndrome that is characterized by cognitive complaints and slow gait. Cardiometabolic multimorbidity (CMM) is associated with an increased risk of dementia.
Hui Zhang, Shuai Jiang, Meng Hao, Yi Li, Zixin Hu, Xiao‐Yan Jiang, Li Jin, Xiaofeng Wang   +7 more
doaj   +3 more sources

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort [PDF]

BMC Medicine, 2019
Background Multimorbidity is associated with higher mortality, but the relationship with cancer and cardiovascular mortality is unclear. The influence of demographics and type of condition on the relationship of multimorbidity with mortality remains ...
Bhautesh Dinesh Jani, Peter Hanlon, Barbara I. Nicholl, Ross McQueenie, Katie I. Gallacher, Duncan Lee, Frances S. Mair   +6 more
doaj   +3 more sources

Multimorbidity in acute ischemic stroke and its impact on short-term mortality: A Chilean nationwide database analysis [PDF]

Journal of Stroke and Cerebrovascular Diseases
Background: Multimorbidity predicts a worse prognosis for various diseases but its impact in people after an acute ischemic stroke (AIS) in developing societies is not well established. We aimed to characterize the pattern of multimorbidity and determine
Francisca González, MPH PhD(c), Ma. Ignacia Allende, MD, Marilaura Nuñez, MD PhD(c), Iris Delgado, PhD, Paula Jakszyn, PhD, Carlos Delfino, MD PhD(c), Craig S. Anderson, MD PhD, Paula Muñoz Venturelli, MD PhD   +7 more
doaj   +3 more sources

Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study [PDF]

European Heart Journal, 2021
AbstractAims The potential difference in the impacts of lifestyle factors (LFs) on progression from healthy to first cardiometabolic disease (FCMD), subsequently to cardiometabolic multimorbidity (CMM), and further to death is unclear.Methods and results We used data from the China Kadoorie Biobank of 461 047 adults aged 30–79 free of heart disease ...
Yuting Han, Yuelin Hu, Canqing Yu, Yu Guo, Pei Pei, Ling Yang, Yiping Chen, Huaidong Du, Dianjianyi Sun, Yuanjie Pang, Ningyu Chen, Robert Clarke, Junshi Chen, Zhengming Chen, Liming Li, Jun Lv   +15 more
openaire   +3 more sources

The prevalence of cardiometabolic multimorbidity and its associations with health outcomes among women in China

Frontiers in Cardiovascular Medicine, 2023
ObjectiveIn China, a limited number of studies focus on women and examine the effect of cardiometabolic multimorbidity (defined as the presence of two or more cardiometabolic diseases) on health outcomes.
Yang Zhao, Yang Zhao, Huan Zhang, Xiaoyun Liu, Allissa Desloge, Qian Wang, Siqi Zhao, Siqi Zhao, Lili Song, Lili Song, Ioanna Tzoulaki, Ioanna Tzoulaki   +11 more
doaj   +1 more source

Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England

Cardiovascular Diabetology, 2022
Objective To assess trends in primary and specialist care consultation rates and average length of consultation by cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), or cardiometabolic multimorbidity exposure status.
Sophia Abner, Clare L. Gillies, Sharmin Shabnam, Francesco Zaccardi, Samuel Seidu, Melanie J. Davies, Tobi Adeyemi, Kamlesh Khunti, David R. Webb   +8 more
doaj   +1 more source

Cardiometabolic Multimorbidity Associated with Moderate and Severe Disabilities: Results from the Study on Global AGEing and Adult Health (SAGE) Wave 2 in Ghana and South Africa

Global Heart, 2023
Background: Integrated management of cardiometabolic diseases is crucial in improving the quality of life of older persons. The objective of the study was to identify clusters of cardiometabolic multimorbidity associated with moderate and severe ...
Peter Otieno, Gershim Asiki, Justice Moses K. Aheto, Calistus Wilunda, Richard E. Sanya, Welcome Wami, Daniel Mwanga, Charles Agyemang   +7 more
doaj   +1 more source

Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression

Alzheimer's & Dementia, 2022
AbstractIntroductionCardiometabolic diseases (CMDs) have been individually associated with adverse cognitive outcomes, but their combined effect has not been investigated.MethodsA total of 2577 dementia‐free participants 60 years of age or older were followed for 12 years to observe changes in cognitive function and to detect incident cognitive ...
Abigail Dove, Anna Marseglia, Ying Shang, Giulia Grande, Davide Liborio Vetrano, Erika J Laukka, Laura Fratiglioni, Weili Xu   +7 more
openaire   +2 more sources

A multivariate genome-wide association study of psycho-cardiometabolic multimorbidity

PLOS Genetics, 2023
Coronary artery disease (CAD), type 2 diabetes (T2D) and depression are among the leading causes of chronic morbidity and mortality worldwide. Epidemiological studies indicate a substantial degree of multimorbidity, which may be explained by shared genetic influences.
Vilte Baltramonaityte, Jean-Baptiste Pingault, Charlotte A. M. Cecil, Priyanka Choudhary, Marjo-Riitta Järvelin, Brenda W. J. H. Penninx, Janine Felix, Sylvain Sebert, Yuri Milaneschi, Esther Walton   +9 more
openaire   +7 more sources